Nominee, KAUST Distinguished Teaching Award, 2023 

Travel Grant, International Society for Experimental Hematology (ISEH), Tokyo, 2001 

Award, Association Nouvelle Recherche Biologique (ANRB), 1999 

Fellowship, Association Recherche contre le Cancer (ARC), 1999–2002 

Gadhoum, S.Z., Merzaban, J.S., & Sackstein, R. Glycan engineering of human CD34+ stem cells enhances their ability to home and reconstitute marrow ablated mice. In preparation. 

Gadhoum, S.Z., & Merzaban, J.S. Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale for CD44-induced AML therapy. Leukemia. 2016; 30(12):2397–2401. 

Abu Samra, D.B., Al-Kilani, A., Hamdan, S.M., Sakashita, K., Gadhoum, S.Z., & Merzaban, J.S. Quantitative characterization of E-selectin interaction with native CD44 and PSGL-1 using a real-time immunoprecipitation-based binding assay. J. Biol. Chem. 2015; 290(35):21213–30. 

Aouida, M., Eid, A., Ali, Z., Cradick, T., Lee, C., Deshmukh, H., Atef, A., AbuSamra, D., Gadhoum, S.Z., Merzaban, J., Bao, G., & Mahfouz, M. Efficient fdCas9 synthetic endonuclease with improved specificity for precise genome engineering. PLoS One. 2015; 10(7):e0133373 

Merzaban, J.S., Burdick, M.M., Gadhoum, S.Z., Dagia, N.M., Chu, J.T., Fuhlbrigge, R.C., & Sackstein, R. Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells. Blood. 2011; 118(7):1774–83. 

Gadhoum, S.Z., & Sackstein, R. CD15 expression in human myeloid cell differentiation is regulated by sialidase activity. Nat. Chem. Biol. 2008; 4(12):751–7. 

Delaunay, J., Lecomte, N., Bourcier, S., Qi, J., Gadhoum, Z., Durand, L., Chomienne, C., Robert-Lézénès, J., & Smadja-Joffe, F. Contribution of GM-CSF and IL-8 to the CD44-induced differentiation of acute monoblastic leukemia. Leukemia. 2008; 22(4):873–6. 

Dagia, N.M., Gadhoum, S.Z., Knoblauch, C.A., Spencer, J.A., Zamiri, P., Lin, C.P., & Sackstein, R. G-CSF induces E-selectin ligand expression on human myeloid cells. Nat. Med. 2006; 12(10):1185–90. 

Maquarre, E., Artus, C., Gadhoum, Z., Jasmin, C., Smadja-Joffe, F., & Robert-Lézénès, J. CD44 ligation induces apoptosis via caspase- and serine protease-dependent pathways in acute promyelocytic leukemia cells. Leukemia. 2005; 19(12):2296–303. 

Gadhoum, Z., Leibovitch, M.P., Qi, J., Dumenil, D., Durand, L., Leibovitch, S., & Smadja-Joffe, F. CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1. Blood. 2004; 103(3):1059–68 

Charrad, R.S., Gadhoum, Z., Qi, J., Glachant, A., Allouche, M., Jasmin, C., Chomienne, C., & Smadja-Joffe, F. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood. 2002; 99(1):290–99. 

Smadja-Joffe, F., Legras, S., Charrad, S., Gadhoum, Z., & Lesveque, J.P. CD44 et hématopoïèse. Hématologie. 1999; 4:339–49. (in French) 

Gadhoum, Z., Delaunay, J., Maquarre, E., Durand, L., Lancereaux, V., Qi, J., Robert-Lezénès, J., Chomienne, C., & Smadja-Joffe, F. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leuk. Lymphoma. 2004; 45(8):1501–10.